Pages that link to "Q34644993"
Jump to navigation
Jump to search
The following pages link to Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study (Q34644993):
Displaying 50 items.
- Sulfonylurea versus metformin monotherapy in patients with type 2 diabetes: a Cochrane systematic review and meta-analysis of randomized clinical trials and trial sequential analysis (Q22241119) (← links)
- Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus (Q24185970) (← links)
- Common medications used by patients with type 2 diabetes mellitus: what are their effects on the lipid profile? (Q26740253) (← links)
- The Association between Sulfonylurea Use and All-Cause and Cardiovascular Mortality: A Meta-Analysis with Trial Sequential Analysis of Randomized Clinical Trials (Q26748870) (← links)
- Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statement (Q26783199) (← links)
- Treating the elderly diabetic patient: special considerations (Q26995176) (← links)
- Treatment of type 2 diabetes, lifestyle, GLP1 agonists and DPP4 inhibitors (Q27021870) (← links)
- Practical combination therapy based on pathophysiology of type 2 diabetes (Q28076530) (← links)
- Understanding and overcoming metformin gastrointestinal intolerance. (Q30240030) (← links)
- Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus. (Q30243879) (← links)
- Validation of methods for assessing cardiovascular disease using electronic health data in a cohort of Veterans with diabetes (Q30740532) (← links)
- Comparative risk of major cardiovascular events associated with second-line antidiabetic treatments: a retrospective cohort study using UK primary care data linked to hospitalization and mortality records (Q31095975) (← links)
- Evaluation of patient-reported outcomes data in structured diabetes education intervention: 2-year follow-up data of patient empowerment programme (Q31130301) (← links)
- Risk of acute kidney injury and survival in patients treated with Metformin: an observational cohort study. (Q33705903) (← links)
- Use of cystatin C to inform metformin eligibility among adult veterans with diabetes (Q33778097) (← links)
- Metformin in peritoneal dialysis: a pilot experience (Q33837650) (← links)
- American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary (Q34081331) (← links)
- Association between intensification of metformin treatment with insulin vs sulfonylureas and cardiovascular events and all-cause mortality among patients with diabetes (Q34109319) (← links)
- Sulfonylurea use and incident cardiovascular disease among patients with type 2 diabetes: prospective cohort study among women (Q34392375) (← links)
- Frailty Attenuates the Impact of Metformin on Reducing Mortality in Older Adults with Type 2 Diabetes (Q34684420) (← links)
- Cardiovascular safety profile of currently available diabetic drugs (Q34971736) (← links)
- Time to be cautious about prescribing sulfonylureas? (Q35076020) (← links)
- Thiazolidinedione and Metformin Use and the Risk of Benign Prostate Hyperplasia in Veterans with Diabetes Mellitus (Q35190607) (← links)
- Effects of CP-900691, a novel peroxisome proliferator-activated receptor α, agonist on diabetic nephropathy in the BTBR ob/ob mouse (Q35498269) (← links)
- Cost effectiveness of dipeptidyl peptidase-4 inhibitors for type 2 diabetes (Q35570938) (← links)
- Reduced vascular events in type 2 diabetes by biguanide relative to sulfonylurea: study in a Japanese Hospital Database (Q35780117) (← links)
- Chinese Herbal Medicine Treatment Improves the Overall Survival Rate of Individuals with Hypertension among Type 2 Diabetes Patients and Modulates In Vitro Smooth Muscle Cell Contractility (Q35877249) (← links)
- Cardiovascular risk associated with the use of glitazones, metformin and sufonylureas: meta-analysis of published observational studies (Q35894680) (← links)
- Diabetes treatment intensification and associated changes in HbA1c and body mass index: a cohort study (Q36038607) (← links)
- Heart healthy equals prostate healthy and statins, aspirin, and/or metformin (S.A.M.) are the ideal recommendations for prostate cancer prevention (Q36080332) (← links)
- The influence of hypoglycemic drugs on exercise-mediated hypoglycemic effects in elderly type 2 diabetic patients (Q36183455) (← links)
- Potential Impact of Prescribing Metformin According to eGFR Rather Than Serum Creatinine (Q36185994) (← links)
- Dissecting the Mechanisms Underlying Unusually Successful Human Health Span and Life Span (Q36406255) (← links)
- Case-control study of oral glucose-lowering drugs in combination with long-acting insulin and the risks of incident myocardial infarction and incident stroke (Q36520595) (← links)
- Falsification Testing of Instrumental Variables Methods for Comparative Effectiveness Research (Q36706682) (← links)
- Risk of hypoglycemia following intensification of metformin treatment with insulin versus sulfonylurea (Q36757698) (← links)
- Metformin and Myocardial Injury in Patients With Diabetes and ST-Segment Elevation Myocardial Infarction: A Propensity Score Matched Analysis. (Q36836016) (← links)
- Patterns of weight change after the diagnosis of type 2 diabetes in Scotland and their relationship with glycaemic control, mortality and cardiovascular outcomes: a retrospective cohort study (Q37133779) (← links)
- Observational research--opportunities and limitations (Q37282191) (← links)
- Pathophysiologic approach to therapy in patients with newly diagnosed type 2 diabetes (Q37577162) (← links)
- Cardiovascular safety of non-insulin pharmacotherapy for type 2 diabetes (Q37620904) (← links)
- Prescription of oral hypoglycemic agents for patients with type 2 diabetes mellitus: A retrospective cohort study using a Japanese hospital database (Q37677872) (← links)
- Characteristics of Chinese herbal medicine usage in ischemic heart disease patients among type 2 diabetes and their protection against hydrogen peroxide-mediated apoptosis in H9C2 cardiomyoblasts (Q37716571) (← links)
- A review of the efficacy and safety of oral antidiabetic drugs (Q38067491) (← links)
- Antidiabetic treatment, stroke severity and outcome (Q38205762) (← links)
- Dipeptidyl peptidase-4 inhibitors can minimize the hypoglycaemic burden and enhance safety in elderly people with diabetes (Q38215452) (← links)
- Observational studies of the association between glucose-lowering medications and cardiovascular outcomes: addressing methodological limitations (Q38248399) (← links)
- Evaluating cardiovascular safety of novel therapeutic agents for the treatment of type 2 diabetes mellitus (Q38258938) (← links)
- Cardiovascular safety of sulphonylureas: over 40 years of continuous controversy without an answer. (Q38364806) (← links)
- Addressing limitations in observational studies of the association between glucose-lowering medications and all-cause mortality: a review (Q38374279) (← links)